New study identifies a strategy to overcome drug resistance in pancreatic cancer

Approximately 835 people in British Columbia will be diagnosed with pancreatic cancer this year. While pancreatic cancer remains one of the most deadly cancers, new research recently published in Cell Reports Medicine has identified a new combination treatment that may overcome drug resistance in pancreatic cancer. 

Dr. Arman Rahmim receives 2020 CIHR Project Grant of $898,876 for five years for his project entitled “Improved Assessment of Disease in Lymphoma Patients using Quantitative PET Imaging”

Congratulations to Dr. Arman Rahmim for being awarded a Spring 2020 CIHR Project Grant of $898,876 for five years for his project entitled “Improved Assessment of Disease in Lymphoma Patients using Quantitative PET Imaging”.

Dr. Shoukat Dedhar receives Cancer Research Society Operating Grant of $120,000 for his project entitled “Overcoming cancer recurrence and metastatic progression by targeting ‘Anastasis’”

Congratulations to Dr. Shoukat Dedhar for being awarded the Cancer Research Society's Operating Grant of $120,000 for two years for his project entitled “Overcoming cancer recurrence and metastatic progression by targeting ‘Anastasis’”.

A new combination treatment targeting “cancer stem cells” may overcome drug resistance in blood cancers

Building on a BC Cancer discovery from decades past, a new combination treatment has shown promise to overcome drug resistance and relapse in people with chronic myeloid leukemia. 

Building off the discovery of an enzyme called integrin-linked kinase (ILK) made by BC Cancer distinguished scientist Dr. Shoukat Dedhar 24 years ago, BC Cancer’s Drs. Xiaoyan Jiang and Shoukat Dedhar have made a significant advancement in understanding the role of this enzyme in blood cancers. 

Back to top